triazolam has been researched along with Hypoglycemia in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosi, F | 1 |
| Ricci, S | 1 |
| Quartesan, R | 1 |
| Moretti, P | 1 |
| Pelicci, G | 1 |
| Pagliacci, C | 1 |
| Nicoletti, I | 1 |
1 other study available for triazolam and Hypoglycemia
| Article | Year |
|---|---|
Effects of acute benzodiazepine administration on growth hormone, prolactin and cortisol release after moderate insulin-induced hypoglycemia in normal women.
Topics: Adult; Female; Flurazepam; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypothalamo-Hypophy | 1986 |